Human Epidermal Growth Factor Receptor 2 positive (HER2+) breast cancer is a subgroup defined by over-expression of the HER2 tyrosine kinase receptor, which transduces biochemical signals across the cell membrane and amplification of the HER2 gene, ErBb2 [3]. This evidence concerns the gene ERBB2 and breast cancer.